Tricida Inc (NASDAQ:TCDA)

8.28
Delayed Data
As of 3:59pm ET
 -0.47 / -5.37%
Today’s Change
8.16
Today|||52-Week Range
44.30
-78.06%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$437.9M

Company Description

Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.

Contact Information

Tricida, Inc.
7000 Shoreline Court
South San Francisco California 94080
P:(415) 429-7800
Investor Relations:

Employees

Shareholders

Other institutional55.15%
Individual stakeholders45.76%
Mutual fund holders26.83%

Top Executives

Gerrit KlaernerPresident, Chief Executive Officer & Director
Geoffrey M. ParkerChief Financial Officer & Senior Vice President
Wilhelm StahlChief Technology Officer & Senior Vice President
Dawn ParsellExecutive Vice President-Clinical Development
Elizabeth A. FaustExecutive Vice President-Medical Affairs